A systematic review and meta-analysis of efficacy and safety of compound glycyrrhizin combined with second-generation non-sedated antihistamine for the treatment of chronic urticaria

Sijue Chen,Wei Cao,Xianjun Xiao,Lu Wang,Renhong Wan,Zihao Zou,Qian Yang,Ying Li

DOI: https://doi.org/10.1080/09546634.2023.2299597

2024-01-03

Journal of Dermatological Treatment

Abstract:BACKGROUND: Chronic urticaria (CU) is a prevalent dermatologic disease that negatively affects life, current therapies remain suboptimal. Hence, there is an urgent need to identify effective and safe treatment.OBJECTIVE: Assess the efficacy and safety of compound glycyrrhizin (CG) combined with second-generation nonsedated antihistamine for the treatment of CU.METHODS: Nine databases were queried to screen RCTs related. Two reviewers independently assessed the risk of bias using Cochrane Collaboration. Primary objective was the total efficiency rate, while secondary was rate of recurrence, adverse events, and cure. Statistical analyses using Review Manager 5.4 and Stata17.RESULTS: Twenty-four RCTs were identified. Significant differences were noted in rate of total efficiency (<i>n</i> = 2649, RR = 1.36, 95%CI:1.30-1.43, <i>p</i> &lt; 0.00001), cure (<i>n</i> = 2649, RR = 1.54, 95%CI:1.42-1.66, <i>p</i> &lt; 0.00001) and recurrence (<i>n</i> = 446, RR = 0.34, 95%CI:0.20-0.58, <i>p</i> &lt; 0.00001) between the combination of CG with second-generation non-sedated antihistamine and antihistamine monotherapy. Contrastingly, adverse events rate (<i>n</i> = 2317, RR = 0.76, 95% CI:0.59-0.97, <i>p</i> = 0.03) was comparable between the two groups. Our results indicated that CG combined with second-generation non-sedated antihistamine could significantly mitigate the symptoms in CU compared with antihistamine monotherapy. No serious adverse events were reported.CONCLUSIONS: CG combined with second-generation nonsedated antihistamine is effective for CU. Nevertheless, higher-quality studies are warranted to validate our results.

dermatology

What problem does this paper attempt to address?

The main aim of this paper is to address the issues of efficacy and safety in the treatment of Chronic Urticaria (CU). Specifically, the study evaluates the efficacy and safety of Compound Glycyrrhizin (CG) combined with second-generation non-sedating antihistamines in the treatment of chronic urticaria through systematic review and meta-analysis.

The core issues of the paper are:
- **Efficacy Evaluation**: Assess the overall efficacy, cure rate, and recurrence rate of the combination therapy of Compound Glycyrrhizin and second-generation non-sedating antihistamines in patients with chronic urticaria.
- **Safety Considerations**: Compare the incidence of adverse events between the combination therapy and the use of antihistamines alone.

### Research Background
- Chronic urticaria is a common skin disease that negatively impacts the quality of life of patients.
- Current treatment methods still have shortcomings, especially under the standard doses of antihistamines, where some patients do not respond ideally.

### Research Methods
- The study included 24 randomized controlled trials (RCTs) involving a total of 2649 patients.
- Different formulations of Compound Glycyrrhizin, including tablets, capsules, or injections, were used and compared with various second-generation non-sedating antihistamines (such as desloratadine, levocetirizine, etc.).

### Main Findings
- The combination of Compound Glycyrrhizin and second-generation non-sedating antihistamines showed significant advantages in overall efficacy, cure rate, and recurrence rate compared to the use of antihistamines alone.
- There was no significant difference in the incidence of adverse events between the two groups, suggesting that the safety of the combination therapy is comparable to that of using antihistamines alone.
- Subgroup analysis of different formulations of Compound Glycyrrhizin and treatment durations further validated these conclusions.

### Conclusion
- The combination of Compound Glycyrrhizin and second-generation non-sedating antihistamines is effective in the treatment of chronic urticaria.
- However, the authors also point out that more high-quality studies are needed to further confirm these results.

In summary, the main purpose of this paper is to evaluate the efficacy and safety of the combination of Compound Glycyrrhizin and second-generation non-sedating antihistamines, with the aim of providing a theoretical basis and support for the clinical treatment of chronic urticaria.